Mesenchymal stem cells (MSCs) were studied by researchers at the Harvard-affiliated Brigham and Women's Hospital (BWH), with their results published in the journal Stem Cells. MSCs – a type of adult stem cell – possess anti-inflammatory and potent …

In a new study published in the journal Stem Cell Reports, researchers reveal that a combination of stem cell transplantation and anti-diabetic medication was able to successfully treat mice with type 2 diabetes. The findings could set the stage for …

Clinical evidence supports a high prevalence of comorbid autoimmune conditions among individuals with AA, such as thyroid disease, type 1 diabetes mellitus, inflammatory bowel disease, and systemic lupus erythematosus [1],[2]. … data demonstrated …

In earlier research, Kieffer and colleagues first showed that hESC-derived pancreatic progenitor cells reversed diabetes in a mouse model of type 1 diabetes. The research team has also recently developed a seven-stage protocol to more quickly convert …

In the future the researchers plan to try transplanting more mature insulin-producing cells into the mouse models in hopes of further reversing the effects of type 2 diabetes. The researchers noted a similar stem cell-based transplantation method …

Stem cell treatment could reverse type 2 diabetes, according to new research. The study, published in Stem Cell Reports and conducted by scientists at the University of British Columbia and BetaLogics, is the first to indicate …

Stem cells – generic cells that haven't yet taken on specialized form and function – have recently been used by scientists at UBC and elsewhere to reverse Type 1 diabetes in mice. In Type 1 diabetes, which usually begins in …